Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
IMDXInsight Molecular Diagnostics Inc.
Filed Mar 26, 2020 · 10-K · 86 days after period end · 0001493152-20-004738
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$7.95M | -$4.50M | -$3.96M | -$3.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 26, 2020 · 86 d after period end
